<DOC>
	<DOCNO>NCT02099500</DOCNO>
	<brief_summary>This open-label , non-randomized , multi center , patient sponsor study Adipose-Derived Stromal Cell ( ASC ) implantation via intramuscular injection patient critical limb ischemia amenable revascularization . The intent clinical study answer question : 1 ) Is propose treatment safe 2 ) Is treatment effective improve disease pathology patient diagnose critical limb ischemia ASCs collect patient 's adipose-derived tissue ( body fat ) . Using local anesthesia , Liposuction perform collect adipose tissue specimen . The adipose tissue transfer laboratory separation adipose tissue derive stem cell . In addition , peripheral blood collect isolation platelet rich plasma , combine ASC 's intramuscular injection lower limb .</brief_summary>
	<brief_title>Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections Treatment Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<criteria>Age ~ 18 year Existence limb ischemia , clinical presentation correspond Rutherford Categories 26 define reporting standard adopt \ Society Vascular Surgeons , correspond LericheFontaine Classification , stag II , III , IV Patients , ischemia ischemic ulceration provide patient angiographic evidence vascular compromise candidate revascularization Stable optimal medical management &gt; 60 day follow : Clopidogrel/aspirin therapy anticoagulation therapy , cholesterol lower agent , and⁄or antihypertensive medication Hematocrit ≥ 28.0 % , White Blood Cell count ≤14,000 , Platelet count ≥ 50,000 Creatinine ≤ 2.5 mg/dL , INR ≤ 1.6 ( unless take warfarin ) PTT &lt; 1.5× control ( avoid bleeding complication ) . INR value patient take warfarin correct prior procedure Patient meet least one follow diagnostic criterion index limb : 1 . ABI &lt; .5mmHg 2 . TcpO2 &lt; 20 mm Hg lie breathe room air , available 3 . Or , nonhealing ulcer due local arterial compromise opportunity revascularization At least one nonhealing distal extremity ischemic ulcer confirm vascular surgeon Up date age gender appropriate cancer screen per American Cancer Society Female pregnant nursing , childbearing potential use reliable method contraception Any medical problem contraindicate tumescent syringe liposuction Life expectancy &lt; 6 month Patient determine nonsurgical candidate due reason 1 . Highrisk medical condition 2 . Unstable cardiac disease 3 . Stroke transient ischemic attack lead limitation low extremity occur within 180 day prior initial screen visit 4 . Severe arthritis musculoskeletal disorder . Systolic blood pressure ( supine ) ≤ 90 mmHg Resting heart rate &gt; 100 bpm Poorly control diabetes mellitus ( HgbA1c &gt; 10 % ) Life‐threatening complication limb ischemia necessitate immediate amputation Uncorrected iliac artery occlusion index side unless correct stent Extensive necrosis index limb condition make amputation inevitable ( Rutherford Category 6 ) Active clinical infection within one week enrollment Treatment immunosuppressant drug Known drug alcohol dependence , factor interfere study conduct interpretation result Not suitable participate opinion principal investigator History cancer ( nonmelanoma skin cancer situ cervical cancer ) within five year precede study entry Unwilling and/or able give write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Lower Limb Ulcer</keyword>
	<keyword>Gangrene</keyword>
	<keyword>Amputation</keyword>
	<keyword>Lower Limb Wound</keyword>
</DOC>